Shuttle Pharmaceuticals Holdings Inc (SHPH)
0.882
-0.02
(-1.78%)
USD |
NASDAQ |
Nov 21, 16:00
0.9535
+0.07
(+8.11%)
After-Hours: 07:31
Shuttle Pharmaceuticals Holdings Net Income (Quarterly): -3.784M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -3.784M |
| June 30, 2024 | -2.031M |
| March 31, 2024 | -1.731M |
| December 31, 2023 | -1.640M |
| September 30, 2023 | -1.793M |
| June 30, 2023 | -2.184M |
| March 31, 2023 | -0.9751M |
| December 31, 2022 | -2.718M |
| Date | Value |
|---|---|
| September 30, 2022 | -0.9984M |
| June 30, 2022 | -0.5973M |
| March 31, 2022 | -0.6818M |
| December 31, 2021 | -0.459M |
| September 30, 2021 | -0.217M |
| June 30, 2021 | -0.3468M |
| March 31, 2021 | -0.1293M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-3.784M
Minimum
Sep 2024
-0.1293M
Maximum
Mar 2021
-1.352M
Average
-0.9984M
Median
Sep 2022
Net Income (Quarterly) Benchmarks
| Oragenics Inc | -2.463M |
| Lixte Biotechnology Holdings Inc | -0.986M |
| Soligenix Inc | -1.719M |
| Tonix Pharmaceuticals Holding Corp | -14.21M |
| NovaBay Pharmaceuticals Inc | -1.212M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.052M |
| EPS Diluted (Quarterly) | -1.59 |
| Enterprise Value | 3.326M |
| Earnings Yield | -475.1% |